NY-COTY
20.4.2020 20:43:06 CEST | Business Wire | Press release
Coty Inc. announced today that Calvin Klein fragrances has achieved a Material Health Certificate at the Silver level from the Cradle to Cradle Products Innovation Institute for Calvin Klein’s first clean and environmentally conscious fragrance, CK EVERYONE Eau de toilette.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200420005792/en/
Silver level material health certification indicates that 100% of the chemical substances in CK EVERYONE Eau de toilette have been assessed and are compliant with the Cradle to Cradle Certified Product Standard material health requirements at the Silver level. These achievements also serve as the foundation of a material health optimization strategy for further improving the environmental safety of the fragrance over time.
Simona Cattaneo, President of Luxury Brands at Coty, said: “We are proud of Coty’s first Cradle to Cradle Material Health certificate for CK EVERYONE Eau de toilette which demonstrates the positive impact of our Beauty That Lasts platform. The Material Health certificate reinforces Coty’s commitment to its sustainability platform, with the objective of building a better business while making a positive contribution towards societal, ethical and environmental change within the beauty industry.”
The Cradle to Cradle Certified™ Material Health Certificate offers a solution to growing industry and consumer interest in knowing more about the chemicals used in products across their supply chains and avoiding chemicals of concern. By using the rigorous, globally recognized material health assessment methodology of the Cradle to Cradle Certified Product Standard, the Material Health Certificate provides manufacturers with a trusted means of assessing, optimizing and verifying their product chemistries for safety and the environment. The material health evaluation of CK EVERYONE Eau de toilette was executed by MBDC, a third-party Cradle to Cradle accredited assessor.
“Achieving a Cradle to Cradle Material Health certificate for CK EVERYONE Eau de toilette is another positive step in moving the beauty industry towards the universal use of materials that are safe, circular and responsible,” said Dr. Christina Raab, Vice President of Strategy and Development for the Institute. “We look forward to Coty’s continued leadership as the company uses the Cradle to Cradle Certified Product Standard as a framework for improving the sustainability of this and other products.”
“We are thrilled to collaborate with Coty on their first Material Health Certificate for CK EVERYONE Eau de toilette,” said Jay Bolus, President of MBDC. “By obtaining a Material Health Certificate, they are communicating their commitment to transparency and that their fragrance is made with healthier materials. Coty is raising the bar for the beauty industry by insisting on product quality based on Cradle to Cradle Design™.”
About the Cradle to Cradle Products Innovation Institute
The Cradle to Cradle Products Innovation Institute is dedicated to powering innovation for the circular economy through products that have a positive impact on people and planet. Through the Cradle to Cradle Certified™ Products Program, the Institute sets the global standard for products that are safe, circular and made responsibly. Cradle to Cradle Certified is used by future-focused designers, brands, retailers and manufacturers across the value chain to innovate and optimize materials and products according to the world’s most advanced science-based measures for material health, product circularity, renewable energy and climate, water and soil stewardship, and social fairness.
The Institute also powers the global shift to a circular economy through partnerships and collaborative initiatives that equip businesses, governments and other stakeholders with the technical solutions and knowledge they need to innovate the way products are designed and made.
The Institute is headquartered in Oakland, California and Amsterdam, the Netherlands with offices in Washington DC. For more information, follow @c2ccertified or visit c2ccertified.org.
About MBDC
MBDC is a firm founded in 1995 by world-renowned architect William McDonough and chemist Dr. Michael Braungart. MBDC originated the Cradle to Cradle Design™ framework and the Cradle to Cradle Certified™ Products Program. MBDC leads companies to create a world of good by assessing product designs and integrating the framework into corporate strategy, communications, operations, and supply chains. Using the process of inventory, assessment and optimization, MBDC provides unique technical expertise to develop sustainable circular economy solutions around material health, material reutilization, renewable energy use, water stewardship and social fairness. MBDC partners with clients to provide scientific assessments and spur design innovation to create a world of good.
For additional information about MBDC, please visit www.mbdc.com
About CK EVERYONE
CK EVERYONE Eau de toilette is a clean and environmentally conscious fragrance, formulated with naturally derived ingredients, naturally derived alcohol, is vegan, recyclable, and is packaged with recycled materials.
CK EVERYONE Eau de toilette is a citrus fragrance that uplifts with zesty organic orange oil, a blue tea accord, and a vibrant cedarwood base creating the perfect combination of clean freshness, sweet sensuality and provocative edge. Master perfumer and creator of the original CK ONE fragrance, Alberto Morillas crafted the clean and genderless fragrance exuding freshness using 77% of naturally derived ingredients.
The CK EVERYONE bottle and packaging were created from recycled materials to honor its purity and simplicity. The ultra-modern transparent glass bottle contains 10% of post-consumer recycled materials and is recyclable with the removal of the pump and the elastic while the folding carton contains 30% of post-consumer recycled materials.
CK EVERYONE is available globally in a 50ml, 100ml, and 200ml, Eau de toilette spray.
About Coty Inc.
Coty is one of the world’s largest beauty companies with an iconic portfolio of brands across fragrance, color cosmetics, hair color and styling, and skin and body care. Coty is the global leader in fragrance, a strong number two in professional hair color & styling, and number three in color cosmetics. Coty’s products are sold in over 150 countries around the world. Coty and its brands are committed to a range of social causes as well as seeking to minimize its impact on the environment.
For additional information about Coty Inc., please visit www.Coty.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200420005792/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom